Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.4500
+0.0550 (13.92%)
At close: Apr 23, 2025

Enzo Biochem Company Description

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.

The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development.

Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry.

The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers.

Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Enzo Biochem, Inc.
Country United States
Founded 1976
Industry Other
Employees 136
CEO Kara Cannon

Contact Details

Address:
21 Executive Blvd
Farmingdale, New York 11735
United States
Phone 631 755 5500
Website enzo.com

Stock Details

Ticker Symbol ENZB
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year August - July
Reporting Currency USD
SIC Code 3826

Key Executives

Name Position
Kara Cannon Chief Executive Officer
Patricia Eckert Chief Financial Officer